机译:人胰岛素抵抗和噻唑烷二酮介导的胰岛素致敏机制
Departments of Medicine, University of California at San Diego, La Jolla, CA 92093;
Departments of Bioengineering, University of California at San Diego, La Jolla, CA 92093;
Departments of Bioengineering, University of California at San Diego, La Jolla, CA 92093;
Departments of Medicine, University of California at San Diego, La Jolla, CA 92093;
Departments of Medicine, University of California at San Diego, La Jolla, CA 92093;
Departments of Medicine, University of California at San Diego, La Jolla, CA 92093;
Pfizer, Inc., La Jolla, CA 92121;
Departments of Bioengineering, University of California at San Diego, La Jolla, CA 92093;
muscle and adipose tissue; transcriptional mechanisms; diabetes; branched chain amino acid (BCAA); inflammation;
机译:人体胰岛素引起的低血糖后胰岛素抵抗的机制:脂解作用
机译:地塞米松诱导人类胰岛素抵抗期间自主机制有助于胰岛素分泌适应性增加的证据
机译:胰岛素的输送方式会影响肝胰岛素敏感物质(HISS)的作用和胰岛素抵抗。
机译:口服活性两亲性人胰岛素类似物,甲氧基(聚乙二醇)己酰基人重组胰岛素(HIM2)的稳定性和物理特性
机译:涉及诱导高活性抗逆转录病毒疗法(HAART)的细胞内机制-诱导骨骼肌胰岛素抵抗和提高胰岛素敏感性的潜在治疗方法。
机译:人胰岛素抵抗和噻唑烷二酮介导的胰岛素致敏机制
机译:人胰岛素抵抗和噻唑烷二酮介导的胰岛素致敏机制